Atherosclerosis News and Research

RSS

Atherosclerosis is the progressive buildup of plaque - the fatty deposits and other cells - in the inner walls of the arteries. The condition is a consequence of elevated cholesterol and for many it's a silent disease, with no visible signs or symptoms. The disease can begin in early adulthood and continues to progress for the rest of a person's life. Despite the serious nature of atherosclerosis, many people do not understand how it develops and progresses.

New model for proteomic cardiovascular risk assessment among chronic kidney disease patients

Chronic kidney disease (CKD) is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. Despite the disease's prevalence - 10 percent of individuals across the globe suffer from CKD - there are limited tools for measuring cardiac risk for CKD patients, until now.

4 Apr 2023

What are the effects of kimchi on human health?

Researchers evaluated the effectiveness of kimchi consumption on overall human health.

4 Apr 2023

Black sea urchin extract shows promise in combating atherosclerosis

A team of Italian scientists has identified potential anti-inflammatory and vasculoprotective effects of red cell extracts of the Black Sea urchin Arbacia lixula. The study has been published in the journal Nutrients.

30 Mar 2023

Capsaicin and its health benefits

Researchers examine the health benefits associated with capsaicin, with a particular focus on how this compound impacts cognition and cardiovascular health.

28 Mar 2023

Researchers identify an enzyme associated with kidney fibrosis in both mice and humans

Researchers at Nagoya University in Japan have identified two enzymes that are involved in macrophage polarization, one of the key factors affecting fibrosis.

22 Mar 2023

Use of chewing tobacco and snuff linked with a two-fold increase in peripheral artery disease risk

A new study in the American Journal of Preventive Medicine, published by Elsevier, investigated the incidence of peripheral artery disease (PAD) among users of smokeless tobacco products.

22 Mar 2023

Severe COVID-19 increases the risk of developing heart disease later in life

Patients who have been hospitalized with severe COVID-19 have permanent changes in their cholesterol 3 months after recovery, according to a study from the University of Oslo. This increases their risk of developing heart disease later in life.

17 Mar 2023

The relationship between intestinal microbiome dysbiosis and atherosclerosis

Researchers investigate the impact of intestinal microbiota dysbiosis on atherosclerotic cardiovascular disease incidence.

15 Mar 2023

Cuproptosis-associated ferroptosis genes linked with immune infiltration in atherosclerosis

Announcing a new article publication for Cardiovascular Innovations and Applications journal. In this study, the authors identify cuproptosis-associated ferroptosis genes in the atherosclerosis microarray of the Gene Expression Omnibus (GEO) database and explored hub gene-mediated immune infiltration in atherosclerosis.

15 Mar 2023

Reversing infertility in sterile mice by reducing high-circulating cholesterol with a bacterial protein

Houston Methodist scientists reversed infertility in sterile mice by reducing high-circulating cholesterol with a bacterial protein, showing further evidence that links high cholesterol to female infertility.

15 Mar 2023

How does the gut microbiome affect muscle strength?

Researchers use fecal microbiome transplantation in mouse models to examine the role of gut microbiota in determining muscle strength.

14 Mar 2023

Examining the effect of hormone replacement therapy on postmenopausal heart disease and cognitive decline

Many are aware of the short-term symptoms often associated with menopause, such as hot flashes, which are attributed to changes in reproductive hormones.

9 Mar 2023

Inhibition of ACLY by 326E represents a promising strategy for treatment of hypercholesterolemia

This new article publication from Acta Pharmaceutica Sinica B, discusses the development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia.

9 Mar 2023

Statin-related residual inflammation predicts cardiovascular events and mortality

A recent Lancet study assessed the importance of low-density lipoprotein cholesterol (LDLC) and high-sensitivity C-reactive protein (CRP) as risk predictors of cardiovascular death, cardiovascular events, and all-cause death among patients subjected to statins.

7 Mar 2023

Atherosclerosis News and Research

Further Reading

New model for proteomic cardiovascular risk assessment among chronic kidney disease patients

What are the effects of kimchi on human health?

Black sea urchin extract shows promise in combating atherosclerosis

Capsaicin and its health benefits

Researchers identify an enzyme associated with kidney fibrosis in both mice and humans

Use of chewing tobacco and snuff linked with a two-fold increase in peripheral artery disease risk

Severe COVID-19 increases the risk of developing heart disease later in life

The relationship between intestinal microbiome dysbiosis and atherosclerosis

Cuproptosis-associated ferroptosis genes linked with immune infiltration in atherosclerosis

Reversing infertility in sterile mice by reducing high-circulating cholesterol with a bacterial protein

How does the gut microbiome affect muscle strength?

Examining the effect of hormone replacement therapy on postmenopausal heart disease and cognitive decline

Inhibition of ACLY by 326E represents a promising strategy for treatment of hypercholesterolemia

Statin-related residual inflammation predicts cardiovascular events and mortality

Lack of sleep can be a major risk factor for cardiovascular disease

Keto-like diet may be associated with elevated risk of cardiovascular events

Association between cardiovascular disease and transportation noise revealed in new research

Lifetime experiences of discrimination linked to increased risk of dementia

An overview of the anti-inflammatory effects of nuts

Study supports the concept of atherosclerosis as a T-cell autoimmune disease targeting the arterial wall

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News